Thrivory Secures $3.5 Million Equity Round and Up to $25 Million in Credit to Accelerate Real-Time Healthcare Payments
Thrivory, a New York-based healthcare fintech and AI company transforming the way medical practices get paid, announced a notable $3.5 million equity funding round coupled with up to $25 million in credit capacity aimed at scaling its real-time payments innovation and expanding market reach. The financing package, announced in November 2025, underscores strong investor confidence in Thrivory’s mission to eliminate reimbursement delays that have long burdened U.S. healthcare providers.
Founded in 2023 by Devon Seitz and Patrick LaVoie, Thrivory has built an AI-driven platform that advances funds against insurance claims for healthcare providers, effectively turning slow reimbursements into near-instant, non-recourse payments. This solution is designed to alleviate cash-flow bottlenecks that often force practices to wait months for insurer payouts, constraining growth, limiting staffing and resource investment, and fueling administrative strain.
The equity portion of the raise was led by Redesign Health, a venture builder and investor focused on launching and scaling innovative healthcare companies. Redesign Health’s leadership in the round reflects its continued commitment to backing companies addressing fundamental challenges within the healthcare system, particularly those leveraging technology to improve financial and operational outcomes for providers.
In addition to the equity raise, Thrivory secured an accordion credit facility anchored by Trinity Capital, a publicly traded alternative asset manager that provides tailored debt and credit solutions to growth-oriented companies. This credit backing significantly increases Thrivory’s capacity to underwrite real-time claim payments, offering financial flexibility as the startup scales its underwriting and treasury operations to support broader adoption of its platform.
The combined funding will be used to accelerate development and expansion of Thrivory’s ThriveNow API, a recently launched capability that embeds same-day claim settlement directly into electronic health record (EHR) and practice management systems. By integrating payment settlement into workflows that providers already use, Thrivory aims to make instant reimbursement a seamless part of daily operations, empowering practices to access revenue quickly without altering billing procedures or incurring debt.
Thrivory’s proprietary AI underwriting is central to its value proposition, predicting claim outcomes with high accuracy and flagging potential denials before submission. The platform advances up to 80% of expected claim value within hours and absorbs the risk of denial, ensuring providers are not subject to clawbacks or collections. By combining predictive analytics with automated reconciliation against remittance data, the company delivers transparency into reimbursement timing and amounts.
Early customer adoption highlights the platform’s impact, with providers reporting stronger financial performance and faster growth after integrating real-time settlement capabilities. According to the company’s announcements, users have experienced accelerated revenue flow and operational stability, with zero losses and zero write-offs to date—metrics that indicate the solution’s effectiveness in addressing cash-flow challenges.
The infusion of credit capacity further enables Thrivory to serve a broader range of healthcare segments, including independent practices, specialty clinics, infusion centers, and other providers facing complex reimbursement cycles. By expanding its underwriting and analytic capabilities, the company aims to support these organizations with flexible working capital solutions that do not require personal guarantees or equity dilution.
Investor enthusiasm for Thrivory’s model reflects a broader trend in healthcare fintech, where solutions that combine financial services with domain-specific technology are increasingly valued. Stakeholders recognize the systemic strain imposed by slow insurer payments and growing denial rates, making Thrivory’s instant settlement offerings particularly timely as providers seek more predictable revenue streams and stronger financial footing.
With the new funding, Thrivory is poised to accelerate its trajectory, strengthening both product innovation and market penetration. Investments will support enhancements to risk models and analytics, bolster underwriting operations, and expand partnerships with EHR and practice management platform vendors to drive deeper integrations. As the company scales, its vision remains centered on redefining how healthcare providers experience cash flow—transforming reimbursement from a delayed, uncertain process into a reliable, near-instant event embedded within existing clinical and financial systems.
